(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYTOREASON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

CYTOREASON

ST13

US500000088701153

Class

9, 42

Filing

88701153

Registration

6399432

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

06/29/2026

Classification

Registered

Trademark type

Word

Nice classes

9, 42

Filing date

11/21/2019

Registration date

06/29/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/29/2021

Last transaction

06/29/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Tel Aviv-Yafo, IL

Examiner

DUONG, ANGELA GAW

Current location

Historical data usage

Holders and representatives

Holders

Cytoreason Ltd.
Cytoreason Ltd.

Representatives

Robyn S. Lederman BROOKS KUSHMAN P.C.

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer software for the purpose of analyzing and researching medicalscientific and clinical data in the field of medical diagnosticsdrug researchdrug developmentdrug deliverymedical treatmentclinical researchpharmaceutical research; downloadable computer software based on artificial intelligence for the purpose of analyzing and researching medicalscientific and clinical data in the field of medical diagnosticsdrug researchdrug developmentdrug deliverymedical treatmentclinical researchpharmaceutical research; downloadable computer software based on machine learning for the purpose of analyzing and researching medicalscientific and clinical data in the field of medical diagnosticsdrug researchdrug developmentdrug deliverymedical treatmentclinical researchpharmaceutical research; downloadable computer software for the analysis and characterization of scientificmedicalclinical data

Class 42

Scientific and technological servicemedicalclinicalbiological researchanalysistesting in the fields of medical diagnosticsdrug researchdrug developmentdrug deliverymedical treatmentclinical researchpharmaceutical research; analysis and research services in the field of medical diagnosticsdrug researchdrug developmentdrug deliverymedical treatmentclinical researchpharmaceutical research; research services for the analysis and characterization of medicalscientificclinical data

Publications

History of USPTO decisions and trademark events.

26 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/29/2026

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

10/29/2024

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

09/25/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/13/2024

ES7R

TEAS SECTION 7 REQUEST RECEIVED

02/27/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/29/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/13/2021

PUBO

PUBLISHED FOR OPPOSITION

04/13/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/24/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/17/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/17/2021

ALIE

ASSIGNED TO LIE

02/16/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/12/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

08/29/2020

GNSL

LETTER OF SUSPENSION E-MAILED

08/29/2020

CNSL

SUSPENSION LETTER WRITTEN

08/29/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/11/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/11/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/11/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/26/2020

GNRT

NON-FINAL ACTION E-MAILED

02/26/2020

CNRT

NON-FINAL ACTION WRITTEN

02/26/2020

DOCK

ASSIGNED TO EXAMINER

02/26/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/27/2019

NWAP

NEW APPLICATION ENTERED

11/25/2019

Continuous trademark protection

Get notified about every new filing that threatens CYTOREASON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.